Track the Canadian Junior Mining Market at the speed of AI

Build a portfolio of Canadian junior mining companies on 6ix and get real-time updates the minute they announce something. Discover investor events, company profiles, and news in one place.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
23h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Yesterday	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
Yesterday	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
Yesterday	Buffalo Potash Files Annual Information Form and New Technical Report
Yesterday	Ionik Announces 30-Day Extension of Senior Debt Facility

About

8.35CAD+0.02 +0.24%

Closed • Updated at 13:16 GMT+00:00

Market Cap$593.89M

P/E Ratio144.71

Volume34.3K

Beta0.40

RSI61.97

Gross Margin35.22%

Health TechnologyPharmaceuticals: Major

Knight Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Knight to Present at the 2026 RBC Capital Markets Global Healthcare Conference in New York City

Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil

Knight Therapeutics Reports First Quarter 2026 Results

Notice of Knight Therapeutics' First Quarter 2026 Results Conference Call

Knight to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

Recent Videos

'Canada's now going to be a major portion of our business': Knight Therapeutics CEO

'Canada's now going to be a major portion of our business': Knight Therapeutics CEO

Mar 20, 2026

Knight Therapeutics Stock: Is This Pharma Hidden Gem Undervalued? GUD Stock Analysis

Knight Therapeutics Stock: Is This Pharma Hidden Gem Undervalued? GUD Stock Analysis

Dec 27, 2025

Knight Therapeutics (TSX: GUD) Interview with CEO Samira Sakhia

Knight Therapeutics (TSX: GUD) Interview with CEO Samira Sakhia

Nov 21, 2025

Oncology Grand Rounds: Preventing Nausea & Vomiting with Chemo - November 13, 2023 [#Repost 2025]

Oncology Grand Rounds: Preventing Nausea & Vomiting with Chemo - November 13, 2023 [#Repost 2025]

Mar 12, 2025

Community Chat

Ask AI

Try asking